Avalo Therapeutics, Inc. - Common Stock — 재무제표 (NASDAQ:AVTX) | MetaTrader

전체 차트 열기 Full chart

Financials

개요 성명 통계

총자산 43.76 M80.21 M33.37 M20.99 M150.73 M116.46 M 총 부채 19.19 M57.13 M44.28 M13.69 M17.7 M33.41 M 자본금 총액 24.56 M23.08 M-10.91 M7.3 M133.03 M83.05 M 총 부채 및 주주자본 43.76 M80.21 M33.37 M20.99 M150.73 M116.46 M 총부채 —32.83 M19.42 M0—— 순부채 —-21.75 M6.24 M-7.42 M——

뉴스

This Small Biotech — Taking On AbbVie, Novartis And Sanofi — Just Catapulted Into A Breakout

CORT Rises on FDA Nod to Lifyorli in Platinum-Resistant Ovarian Cancer

BTIG 선정, 2026년 최고 헬스케어 주식

Top Healthcare Stocks for This Year According to BTIG

Avalo Therapeutics Stock Has More Than 200% Upside? Analyst Breaks Down Bull And Bear Case - Avalo Therapeutics (NASDAQ:AVTX)

아발로 테라퓨틱스, Guggenheim ’매수’ 의견에 주가 상승

Avalo Therapeutics stock rises after Guggenheim initiates with Buy rating

Guggenheim, Avalo Therapeutics에 ’매수’ 등급 개시

Guggenheim initiates Avalo Therapeutics stock with Buy rating on IL-1β therapy

Avalo Therapeutics, H.C. Wainwright ’매수’ 등급 유지

Avalo Therapeutics stock maintains Buy rating at H.C. Wainwright ahead of trial data

This Valvoline Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday - Avalo Therapeutics (NASDAQ:AVTX), Lexeo Therapeutics (NASDAQ:LXEO)